홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

3-Nitro-n-[1-(4-pyridyl)piperidin-4-ylmethyl]pyridine-2-amine → N2-[1-(4-pyridyl)piperidin-4-ylmethyl]-2,3-pyridinediamine

HRID 49840
인쇄

반응식

HRID 49840 반응식
[N+:1]([C:4]1[C:5]([NH:10][CH2:11][CH:12]2[CH2:17][CH2:16][N:15]([C:18]3[CH:23]=[CH:22][N:21]=[CH:20][CH:19]=3)[CH2:14][CH2:13]2)=[N:6][CH:7]=[CH:8][CH:9]=1)([O-])=O>[Pd]>[N:21]1[CH:22]=[CH:23][C:18]([N:15]2[CH2:16][CH2:17][CH:12]([CH2:11][NH:10][C:5]3[C:4]([NH2:1])=[CH:9][CH:8]=[CH:7][N:6]=3)[CH2:13][CH2:14]2)=[CH:19][CH:20]=1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 1

HCID 234977553-Nitro-n-[1-(4-pyridyl)piperidin-4-ylmethyl]pyridine-2-amine

생성물 1

HCID 12150690N2-[1-(4-pyridyl)piperidin-4-ylmethyl]-2,3-pyridinediamine수율 97.1%

시약·촉매·용매 1

HCID 23938Palladium촉매

실험 절차

Using a similar procedure to that described in Example 2, Part C, 3-nitro-N-[1-(4-pyridyl)piperidin-4-ylmethyl]pyridine-2-amine (340 mg, 1.09 mmol) and 10% palladium on carbon (200 mg) yielded 300 mg of the title compound, which was used without further purification.

출처 및 근거

ORD 기록
ord-03bbc50c157749ee9b5b92ccfd8c784d
이 페이지에서참가 물질실험 절차출처 및 근거반응 노트
출처 데이터셋
uspto-grants-2004_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06710057B2

반응 노트